Int. Journal of Generic Drugs
USA Edition

Locum International Press

Issues Numbers 1 - 8
Each volume contains eight issues per year.

The International Journal of Generic Drugs publishes articles reviews and papers on all aspects of Generic and Innovative Drug Development from preformulation to aspects of regulatory strategy. Emphasis is placed on the US exposure of the Generic Drug Industry with special reference to the on-time development of ANDA submissions.

The Chemistry, Manufacture and Controls (CMC) section of NDA development cover hands-on nuts-and- bolts developmental issues that vary across the full drug development spectrum from documentation requirements, excipients specifications, development (pre-to-final) formulation, scale-up, analytical, cleaning and process validation protocols necessary for the entire drug development process.

The overall objective in generic / CMC drug development is to get the newly developed product to the market place on time. The Journal attempts to clarify and simplify development and regulatory issues to achieve this crucial objective.

80 - 95 pp illustrated b/w & color
Subscription Option Availability Print/CD/PDF via e-mail/Online

$1499.00 - Print Edition (single-user airmail print edition worldwide)
$1699.00 - Corporate single license single pharma campus - (Print / CD)
$1999.00 - Corporate multiple-user license - (includes Print + CD edition maximizes distribution and readership for multiple pharma campus).

USA volume starts annually in March - Euro in June & Pacific Rim in September.

Online	DOWNLOAD from this JOURNAL	USA	Euro	Pacific
	The Journal Title and Cover Page >
	The Journal's Annual Calendar >
	List of Worldwide Subscription Agents >

The Journals in prrint or electronic CD are ordered via Locum International Checkout for international subscriptions or by Google Checkout (for USA subscriptions and confirmed by e-mail or Fax

Order by fax worldwide Euro, EU, India, Pacific Rim
Global sales +972-50-896-5523

US / Canada / Mexico/ ME / South America / Asia
+1-561-431-2620